comprehensive -WSS

comprehensive

author：focus 2025-09-27 22:57:12 - browse：4

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Medical device trials still don't enroll enough women, study finds

WSS

Can medical device makers keep up in the race to treat obesity?

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

FDA approves first new drug developed for postpartum depression

Cheap, fast test for Zika and dengue could cost just $1

My daughter's legacy lives on through her writing, phage therapy

Living organ donors deserve priority status for transplants

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Teladoc has a new CEO, but challenges remain the same

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

California wildfire smoke linked to 52,000 early deaths, study says

Medical leaders decry Supreme Court decision on affirmative action

Coercive sterilizations revealed by STAT prompt outrage

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Curing rare childhood diseases will falter unless Congress steps up

Activists slam private health insurers over coverage restrictions

Cheap, fast test for Zika and dengue could cost just $1

explore

Reanimated hearts work just as well for transplants, study finds

5 takeaways from STAT's examination of Zynex Medical

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Medical device trials still don't enroll enough women, study finds

The thinking behind the controversial eating disorder chatbot Tessa

Bispecific antibodies are next new thing in cancer immunotherapy

hotspot

focus

entertainment

focus